Literature DB >> 19648063

ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling.

Hiroshi Watanabe1, Daniel W Kaiser, Seiko Makino, Calum A MacRae, Patrick T Ellinor, Brian S Wasserman, Prince J Kannankeril, Brian S Donahue, Dan M Roden, Dawood Darbar.   

Abstract

BACKGROUND: The angiotensin-converting enzyme (ACE) gene contains a common polymorphism based on the insertion (I) or deletion (D) of a 287-bp intronic DNA fragment. The D allele is associated with higher ACE activity and thus higher angiotensin II levels. Angiotensin II stimulates cardiac fibrosis and conduction heterogeneity.
OBJECTIVE: The purpose of this study was to determine whether the ACE I/D polymorphism modulates cardiac electrophysiology.
METHODS: Three different cohorts of patients were studied: 69 patients with paroxysmal lone atrial fibrillation (AF), 151 patients with structural heart disease and no history of AF, and 161 healthy subjects without cardiovascular disease or AF. Patients taking drugs that affect cardiac conduction were excluded from the study. ECG parameters during sinus rhythm were compared among the ACE I/D genotypes.
RESULTS: The ACE I/D polymorphism was associated with the PR interval and heart block in the lone AF cohort. In multivariable linear regression models, the D allele was associated with longer PR interval in the lone AF and heart disease cohorts (12.0-ms and 7.1-ms increase per D allele, respectively). P-wave duration showed a similar trend, with increase in PR interval across ACE I/D genotypes in the lone AF and heart disease cohorts.
CONCLUSION: The ACE D allele is associated with electrical remodeling in patients with lone AF and in those with heart disease, but not in control subjects. ACE activity may play a role in cardiac remodeling after the development of AF and heart disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648063      PMCID: PMC2740737          DOI: 10.1016/j.hrthm.2009.05.014

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  34 in total

1.  Effects of the renin-angiotensin system on the current I(to) in epicardial and endocardial ventricular myocytes from the canine heart.

Authors:  H Yu; J Gao; H Wang; R Wymore; S Steinberg; D McKinnon; M R Rosen; I S Cohen
Journal:  Circ Res       Date:  2000-05-26       Impact factor: 17.367

2.  Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation.

Authors:  Francesca Gensini; Luigi Padeletti; Cinzia Fatini; Elena Sticchi; Gian Franco Gensini; Antonio Michelucci
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

3.  Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine.

Authors:  T T Zhang; K Takimoto; A F Stewart; C Zhu; E S Levitan
Journal:  Circ Res       Date:  2001-03-16       Impact factor: 17.367

4.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.

Authors:  A Goette; T Staack; C Röcken; M Arndt; J C Geller; C Huth; S Ansorge; H U Klein; U Lendeckel
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

5.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

Authors:  Hong D Xiao; Sebastien Fuchs; Duncan J Campbell; William Lewis; Samuel C Dudley; Vijaykumar S Kasi; Brian D Hoit; George Keshelava; Hui Zhao; Mario R Capecchi; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy.

Authors:  M V Raynolds; M R Bristow; E W Bush; W T Abraham; B D Lowes; L S Zisman; C S Taft; M B Perryman
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

7.  Renin-angiotensin system gene polymorphisms and atrial fibrillation: a regression approach for the detection of gene-gene interactions in a large hospitalized population.

Authors:  Chia-Ti Tsai; Juey-Jen Hwang; Fu-Tien Chiang; Yi-Chih Wang; Chuen-Den Tseng; Yung-Zu Tseng; Jiunn-Lee Lin
Journal:  Cardiology       Date:  2008-02-01       Impact factor: 1.869

8.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

Authors:  F Cambien; O Poirier; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; J M Bard; L Bara; S Ricard
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

9.  Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.

Authors:  Koichiro Kumagai; Hideko Nakashima; Hidenori Urata; Naoki Gondo; Kikuo Arakawa; Keijiro Saku
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

10.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

View more
  8 in total

1.  A genetic contribution to risk for postoperative junctional ectopic tachycardia in children undergoing surgery for congenital heart disease.

Authors:  Kristie Y Borgman; Andrew H Smith; Jill P Owen; Frank A Fish; Prince J Kannankeril
Journal:  Heart Rhythm       Date:  2011-07-06       Impact factor: 6.343

2.  A common angiotensin-converting enzyme polymorphism and preoperative angiotensin-converting enzyme inhibition modify risk of tachyarrhythmias after congenital heart surgery.

Authors:  Andrew H Smith; English C Flack; Kristie Y Borgman; Jill P Owen; Frank A Fish; David P Bichell; Prince J Kannankeril
Journal:  Heart Rhythm       Date:  2014-01-01       Impact factor: 6.343

3.  Relation of Body Mass Index to Symptom Burden in Patients withAtrial Fibrillation.

Authors:  Brandon Chalazan; Deanna Dickerman; Arvind Sridhar; Maureen Farrell; Katherine Gayle; David C Samuels; Benjamin Shoemaker; Dawood Darbar
Journal:  Am J Cardiol       Date:  2018-05-01       Impact factor: 2.778

Review 4.  Genetics of atrial fibrillation: implications for future research directions and personalized medicine.

Authors:  Steven A Lubitz; Cevher Ozcan; Jared W Magnani; Stefan Kääb; Emelia J Benjamin; Patrick T Ellinor
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-06

5.  Polymorphisms of renin-angiotensin-aldosterone system gene in chinese han patients with nonfamilial atrial fibrillation.

Authors:  Li-Qun Zhao; Zu-Jia Wen; Yong Wei; Juan Xu; Zheng Chen; Bao-Zhen Qi; Zhimin Wang; Zhi-Ming Wang; Yong-Yong Shi; Shao-Wen Liu
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

Review 6.  Personalized medicine and atrial fibrillation: will it ever happen?

Authors:  Steven A Lubitz; Patrick T Ellinor
Journal:  BMC Med       Date:  2012-12-04       Impact factor: 8.775

7.  Association of angiotensin-converting enzyme gene I/D and CYP11B2 gene -344T/C polymorphisms with lone atrial fibrillation and its recurrence after catheter ablation.

Authors:  Xian-Ling Zhang; Li-Qun Wu; Xu Liu; Yi-Qing Yang; Hong-Wei Tan; Xin-Hua Wang; Li Zhou; Wei-Feng Jiang; Zheng Li
Journal:  Exp Ther Med       Date:  2012-07-31       Impact factor: 2.447

8.  Combined effects of AKT serine/threonine kinase 1 polymorphisms and environment on congenital heart disease risk: A case-control study.

Authors:  Jianxun Zhao; Zhi Zeng
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.